{"id":"https://openalex.org/W2401650528","doi":null,"title":"Strategies for dealing with reactive intermediates in drug discovery and development.","display_name":"Strategies for dealing with reactive intermediates in drug discovery and development.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2401650528","mag":"2401650528","pmid":"https://pubmed.ncbi.nlm.nih.gov/14982156"},"language":"en","primary_location":{"id":"pmid:14982156","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14982156","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015797798","display_name":"Alaa-Eldin F. Nassar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alaa-Eldin F Nassar","raw_affiliation_strings":["Wyeth Research, Department of Drug Metabolism, 500 Arcola Road, Collegeville, PA 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Department of Drug Metabolism, 500 Arcola Road, Collegeville, PA 19426, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064826824","display_name":"Arturo Lopez\u2010Anaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arturo Lopez-Anaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8832,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.84573063,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"7","issue":"1","first_page":"126","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.3935999870300293,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.3935999870300293,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.20260000228881836,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.19030000269412994,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiosyncratic-adverse-drug-reactions","display_name":"idiosyncratic drug reactions","score":0.9559999704360962},{"id":"https://openalex.org/keywords/reactive-metabolites","display_name":"reactive metabolites","score":0.8389999866485596},{"id":"https://openalex.org/keywords/reactive-intermediates","display_name":"reactive intermediates","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8309999704360962},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6970000267028809},{"id":"https://openalex.org/keywords/covalent-attachment","display_name":"covalent binding","score":0.9010000228881836},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7947722673416138},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6838126182556152},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6224294900894165},{"id":"https://openalex.org/C192937433","wikidata":"https://www.wikidata.org/wiki/Q2134627","display_name":"Reactive intermediate","level":3,"score":0.5976170301437378},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.49922847747802734},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41340476274490356},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.39461371302604675},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3471125364303589},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17009767889976501},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15481910109519958},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005609","descriptor_name":"Free Radicals","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005609","descriptor_name":"Free Radicals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:14982156","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14982156","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},{"id":"mag:2401650528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14982156","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1595407654","https://openalex.org/W2008462293","https://openalex.org/W2008261434","https://openalex.org/W1585256759","https://openalex.org/W1498927262","https://openalex.org/W1989267015","https://openalex.org/W2154119460","https://openalex.org/W2179388831","https://openalex.org/W1257197030","https://openalex.org/W2131146008"],"abstract_inverted_index":{"Idiosyncratic":[0],"drug":[1,8,19,27,34,102,123,136,196,203],"reactions":[2,103],"(IDRs;":[3],"a":[4,15,98],"specific":[5],"type":[6],"of":[7,18,41,57,59,72,78,81,92,100,106,112,132,151,195,201],"toxicity":[9],"characterized":[10],"by":[11,38],"delayed":[12],"onset)":[13],"are":[14,36,95,127,148],"major":[16],"complication":[17],"therapy":[20],"that":[21],"need":[22],"to":[23,32,45,53,155,174,185,189],"be":[24,183],"addressed":[25],"during":[26],"discovery":[28,124,204],"and":[29,61,76,104,114,125,129,140,161,164,178,205],"development.":[30],"Efforts":[31],"improve":[33,190],"safety":[35,193],"hampered":[37],"the":[39,54,62,73,90,130,149,172,187,191,202],"lack":[40],"an":[42],"accepted":[43],"approach":[44],"predict":[46],"IDRs,":[47],"which":[48,168],"in":[49,67,122,135,138,141],"turn":[50],"is":[51,83,144],"due":[52],"low":[55],"incidence":[56],"occurrence":[58],"IDRs":[60,82],"various":[63,199],"potential":[64,115,173,188],"mechanisms":[65,88],"involved":[66],"these":[68,180],"reactions.":[69],"The":[70,109],"concept":[71],"relative":[74,110],"rarity":[75],"formation":[77,91],"reactive":[79,93,107,120,157,176],"metabolite":[80],"briefly":[84],"described.":[85],"Hypothetical":[86],"chemical":[87],"for":[89,117,166],"metabolites":[94],"summarized,":[96],"including":[97],"classification":[99],"adverse":[101],"types":[105],"metabolites.":[108],"merits":[111,150],"current":[113],"strategies":[116,165],"dealing":[118],"with":[119],"intermediates":[121,177],"development":[126,206],"examined,":[128],"significance":[131],"covalent":[133,162],"binding":[134],"discovery/development":[137],"vitro":[139],"vivo":[142],"systems":[143],"considered.":[145],"Also":[146],"discussed":[147],"tools":[152],"(screening":[153],"methods":[154],"trap":[156],"intermediates,":[158],"enzyme":[159],"inhibition":[160],"binding)":[163],"predicting":[167],"new":[169],"drugs":[170],"have":[171,186],"produce":[175],"IDRs;":[179],"approaches":[181],"may":[182],"considered":[184],"overall":[192],"profile":[194],"candidates":[197],"at":[198],"stages":[200],"process.":[207]},"counts_by_year":[{"year":2022,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}